Pakistan to pilot Alibaba DAMO Academy’s multi-cancer screening AI in public hospitals

Partnerships to deploy AI screening

Alibaba DAMO Academy (阿里巴巴达摩院) has signed memoranda of understanding with Pakistan’s Capital Hospital in Islamabad, Khawaja Muhammad Safdar Medical College in Sialkot, and local cloud services firm Sky47 to promote and implement its multi-cancer screening AI, according to an announcement on DAMO’s website. The effort aims to bolster Pakistan’s digital health capabilities and strengthen cancer prevention and early detection across government-affiliated institutions. Specific deployment timelines and program scope were not disclosed.

Why it matters

Pakistan faces high cancer incidence and low screening coverage, particularly outside major cities. AI tools that assist clinicians in triage, image analysis, or risk assessment could help stretch limited specialist capacity and standardize screening quality. Can AI narrow Pakistan’s screening gap and catch more cases earlier? Clinical validation in local settings and integration with existing care pathways will determine impact.

Geopolitics and data

The move underscores how Chinese tech firms are exporting healthcare AI to emerging markets amid intensifying U.S.–China tech competition. Alibaba Group (阿里巴巴集团) has been pushing its research outputs overseas as domestic growth slows and export controls complicate access to advanced chips. While healthcare AI can run on a range of hardware, cross-border health data governance looms large. The inclusion of Sky47 suggests an emphasis on local infrastructure, though data residency, privacy safeguards, and regulatory oversight were not detailed and will be closely watched.

What to watch

Key questions remain: Which cancers will be prioritized, how will accuracy be validated against local population data, and what training will frontline staff receive? Reportedly, the parties will collaborate to adapt and scale the technology, but regulatory approvals, procurement, and sustained funding will shape outcomes. If the pilots deliver measurable gains in early detection, Pakistan could become a reference market for broader regional rollouts of Chinese-developed medical AI.